Cell Invent Overview
- Year Founded
-
2019

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Cell Invent General Information
Description
Developer of drug discovery screening methods designed to offer new ways to find cures for Alzheimer's. The company's y phenotype-based methods use direct conversion techniques that turn skin cells into brain cells in four weeks which allows for cellular reprogramming, enabling Alzheimer's patients to preserve cellular age and be eventually cured of the disease.
Contact Information
Website
www.cellinvent.comCorporate Office
- Scheeletorget 1
- 223 63 Lund
- Sweden
Corporate Office
- Scheeletorget 1
- 223 63 Lund
- Sweden
Cell Invent Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Oct-2022 | Completed | Out of Business | |||
1. Early Stage VC | 07-Nov-2019 | Completed | Startup |
Cell Invent Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary |
Cell Invent FAQs
-
When was Cell Invent founded?
Cell Invent was founded in 2019.
-
Where is Cell Invent headquartered?
Cell Invent is headquartered in Lund, Sweden.
-
What industry is Cell Invent in?
Cell Invent’s primary industry is Drug Discovery.
-
Is Cell Invent a private or public company?
Cell Invent is a Private company.
-
What is Cell Invent’s current revenue?
The current revenue for Cell Invent is
. -
How much funding has Cell Invent raised over time?
Cell Invent has raised $122K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »